Adverse birth outcomes related to concentrations of per- and polyfluoroalkyl substances (PFAS) in maternal blood collected from pregnant women in 1960–1966

Prior animal and epidemiological studies suggest that per- and polyfluoroalkyl substances (PFAS) exposure may be associated with reduced birth weight. However, results from prior studies evaluated a relatively small set of PFAS. Determine associations of gestational PFAS concentrations in maternal s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Environmental research 2024-01, Vol.241, p.117010-117010, Article 117010
Hauptverfasser: Zheng, T., Kelsey, K., Zhu, C., Pennell, K.D., Yao, Q., Manz, K.E., Zheng, Y.F., Braun, J.M., Liu, Y., Papandonatos, G., Liu, Q., Shi, K., Brochman, S., Buka, S.L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Prior animal and epidemiological studies suggest that per- and polyfluoroalkyl substances (PFAS) exposure may be associated with reduced birth weight. However, results from prior studies evaluated a relatively small set of PFAS. Determine associations of gestational PFAS concentrations in maternal serum samples banked for 60 years with birth outcomes. We used data from 97 pregnant women from Boston and Providence that enrolled in the Collaborative Perinatal Project (CPP) study (1960–1966). We quantified concentrations of 27 PFAS in maternal serum in pregnancy and measured infant weight, height and ponderal index at birth. Covariate-adjusted associations between 11 PFAS concentrations (>75% detection limits) and birth outcomes were estimated using linear regression methods. Median concentrations of PFOA, PFNA, PFHxS, and PFOS were 6.189, 0.330, 14.432, and 38.170 ng/mL, respectively. We found that elevated PFAS concentrations during pregnancy were significantly associated with lower birth weight and ponderal index at birth, but no significant associations were found with birth length. Specifically, infants born to women with PFAS concentrations ≥ median levels had significantly lower birth weight (PFOS: β = −0.323, P = 0.006; PFHxS: β = −0.292, P = 0.015; PFOA: β = −0.233, P = 0.03; PFHpS: β = −0.239, P = 0.023; PFNA: β = −0.239, P = 0.017). Similarly, women with PFAS concentrations ≥ median levels had significantly lower ponderal index (PFHxS: β = −0.168, P = 0.020; PFHxA: β = −0.148, P = 0.018). Using data from this US-based cohort study, we found that 1) maternal PFAS levels from the 1960s exceeded values in contemporaneous populations and 2) that gestational concentrations of certain PFAS were associated with lower birth weight and infant ponderal index. Additional studies with larger sample size are needed to further examine the associations of gestational exposure to individual PFAS and their mixtures with adverse birth outcomes. •Using the maternal serum samples banked in early 1960s from a US-based cohort study, the study found serum levels of PFAS were much higher than today's population values.•The study found that gestational concentrations of certain PFAS were associated with lower birth weight and infant ponderal index.
ISSN:0013-9351
1096-0953
DOI:10.1016/j.envres.2023.117010